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Abstract
In order to fully understand protein kinase networks, new methods are needed to identify regulators and substrates of
kinases, especially for weakly expressed proteins. Here we have developed a hybrid computational search algorithm that
combines machine learning and expert knowledge to identify kinase docking sites, and used this algorithm to search the
human genome for novel MAP kinase substrates and regulators focused on the JNK family of MAP kinases. Predictions were
tested by peptide array followed by rigorous biochemical verification with in vitro binding and kinase assays on wild-type
and mutant proteins. Using this procedure, we found new ‘D-site’ class docking sites in previously known JNK substrates
(hnRNP-K, PPM1J/PP2Czeta), as well as new JNK-interacting proteins (MLL4, NEIL1). Finally, we identified new D-site-
dependent MAPK substrates, including the hedgehog-regulated transcription factors Gli1 and Gli3, suggesting that a direct
connection between MAP kinase and hedgehog signaling may occur at the level of these key regulators. These results
demonstrate that a genome-wide search for MAP kinase docking sites can be used to find new docking sites and substrates.
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Introduction
Protein kinases – enzymes which catalyze covalent addition of
phosphate groups to substrate proteins – are essential components
of the vast majority of eukaryotic signal transduction and
regulatory networks. The human proteome contains just over
500 protein kinases [1], while it has been estimated that at
least one-third of all proteins in a typical mammalian cell are
phosphorylated [2]. Given these numbers, it is clear that most
protein kinases have many different physiological substrates, and
that the majority of these substrates remain to be identified.
Many biochemical methodshavebeendeveloped to identify novel
substrates of protein kinases, such as mass-spectrometry, 2D gel
electrophoresis,chemicaltagsusedforinvitrophosphorylationassays,
and others, but most of these methods are biased against weakly
expressed proteins (reviewed in [2,3]). In contrast, computational
scanning of genomes to predict novel substrates is blind to protein
expression levels, and will also not miss those proteins that are
only expressed in rarely studied cell types. The success of such
approaches, however, is predicated upon the existence of sufficiently
non-degenerate sequence patterns to search for.
Protein kinases phosphorylate serine/threonine or tyrosine
residues in proteins, and a few residues on either side of the
target phosphoacceptor residue typically also influence kinase-
target selection [4,5]. For example, both cyclin-dependent kinases
and mitogen-activated protein kinases recognize a core motif
consisting of Ser/Thr-Pro, which is influenced by nearby residues
[6]. Phosphorylation-site consensus motifs have been compiled
from known examples and from data obtained using peptide
libraries [7,8]. Unfortunately, these motifs are typically short and
degenerate, so that they are found in many proteins by chance.
Hence, while there have been successes using these motifs to find
new substrates (e.g. [9,10,11]), this approach has not generally
been applied systematically on a genomic level.
Substrate prediction based on target peptide specificity is even
more problematic for those kinases that recruit their substrates via
interactions outside of the catalytic pocket [12]. Work over the
past 15 years or so has established the paradigm that many protein
kinases bind with relatively high affinity to interaction motifs on
substrates that are distal to the target phosphorylation site(s)
[13,14,15], and that these interactions can be crucial for efficient
signal transmission [16]. This type of ‘‘docking’’ strategy is used
extensively in mitogen-activated protein kinase (MAPK) signaling
[16,17]. For example, when the MAP kinase JNK2 phosphorylates
its transcription factor target c-Jun, it first tethers itself to a dock-
ing site located within residues 30–45 of c-Jun, and then
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this docking site drastically reduces the ability of JNK2 to
phosphorylate these residues [18].
Although there are several classes of MAPK-docking site, many
of the known substrates of MAP kinases contain a docking motif
known as the ‘D-site’ (see Fig. 1). D-sites are also found in MAPK-
regulating proteins such as MAPK kinases (MKKs), scaffold
proteins and MAPK phosphatases. The D-site consensus consists
of a basic cluster of 1–4 residues, a short spacer, and a
hydrophobic-X-hydrophobic submotif. Crystallographic and mu-
tagenesis studies have established that D-sites on substrates and
regulators bind in an extended fashion to complementary surface
patches and grooves on their cognate MAPKs [19].
MAPKs are essential components of eukaryotic signal trans-
duction networks that enable cells to respond appropriately to
growth factors, differentiation cues, stresses, and other signals [20].
MAPK pathways are dysregulated in many diseases, including
cancer, developmental disorders, degenerative diseases (e.g.
Alzheimer’s, Parkinson’s, Huntington’s, muscular dystrophy) and
metabolic disorders (e.g. obesity and diabetes) [21,22]. Many
substrates of MAPKs have been identified [23,24], but given the
widespread involvement of MAPKs in fundamental and disease
processes, it is suspected that many more remain to be found [25].
In addition, MAPK target phosphosites are too degenerate to use
for genome-scale screening [26]. With this in mind, we developed
a program to search genome sequences for putative D-sites, with
the aim of identifying novel MAPK substrates and regulators.
Here we report the success of this approach, when applied to the
human genome, both in identifying previously unknown D-sites in
known substrates, and in discovering novel D-site-containing
MAPK substrates.
Results
An algorithm for detecting MAPK-docking sites
In mammalian cells, four major MAPK pathways have
been characterized: ERK1/2, JNK, p38, and ERK5 [27,28].
D-site-mediated interactions are used extensively by the first three
of these [29], and perhaps by ERK5 as well [30]. While some D-
sites show selectivity in their ability to bind to either the ERK,
JNK or p38 families of MAPKs [31], other D-sites bind to
members of more than one MAPK family [17]. This suggests that
it is both possible and desirable to devise a search procedure that
can utilize family-specific information, and also suggests that there
is hidden information, outside the core consensus, that dictates
family preferences. For these reasons we decided to focus on
developing a search procedure that could identify novel substrates
and regulators of the JNK family of MAPKs.
We believed that our recent characterization of four new JNK
D-sites [32,33] had pushed the number of literature-verified sites
towards the critical mass needed to implement a machine-learning
approach [34]. A profile Hidden Markov Model (HMM)
architecture, which statistically represents a pattern of position-
specific conservation for a series of related sequences, is a
probabilistic machine learning approach that has the potential to
discover patterns in sets of data that are difficult to notice by direct
observation [35]. HMMs have proven useful, for example, in
sequence alignment of protein families and prediction of novel
family members [36,37], prediction of signal peptides [38], and
prediction of p53-binding sites [39]. HMMs also form the
foundation of Pfam’s homology searching capabilities [40]. Within
the profile HMM architecture, a ‘‘training set’’ of validated
sequences is used to update a set of emission and transition
probability matrices. Following enough iterations to converge each
parameter’s value, the HMM can be used to compute the
probability that any test sequence is related to the training set.
Essentially, the computer infers what the sequences in the training
set have in common, and then evaluates the probability that a test
sequence will be generated by the same rules it has inferred from
the training set [41,42,43].
To evaluate the utility of an HMM-based approach for finding
novel D-sites, a list of 20 proteins containing functionally verified
JNK-docking sites was compiled from our own results and the work
of many others [17,18,44,45,46,47,48,49,50,51,52,53,54,55,56]
(Fig. 1B). Members of the training set included D-sites from the
JNK activating kinases MKK4 and MKK7 [32,33], JNK scaffold
proteins such as JIP1-3, JIP4/SPAG9, JSAP1, and beta-arrestin2
[46,47,48,49,55,56], and JNK substrates such as the transcription
factors c-Jun, ATF2, Elk-1 and Net [18,45,54]. We limited the
training set to experimentally-validated JNK-docking sites, and
excluded those D-sites known to bind preferentially to ERK or p38
over JNK, as well as those which had not been tested with JNK. We
also excluded MAPK phosphatases from our training set because of
evidencethat theyuseanextendeddockingmotif[57].Thistraining
set was used to train a profile HMM architecture designated ‘D-
learner’ (see Methods for further details); the trained HMM was
designated D-learner.T1 (short for ‘D-learner trained with Training
Set #1’).
Validation of the HMM algorithm
A training set of only 20 members is close to the minimum
number needed to derive a useful HMM; this small set was
necessitated by our decision to limit the training set only to those
D-sites that were literature verified. Therefore, several tests were
carried out to assess the ability of D-learner.T1 to accurately
discriminate D-sites from other sequences.
First, the probabilistic ‘‘Viterbi score’’ (see Methods) given by
D-learner.T1 to each member of the training set was computed.
The HMM gave the best score to training set members JIP1/
MAPK8IP1 and JIP2/MAPK8IP2 (2.4E-14 and 3.3E-17, respec-
tively), and the ‘worst’ score to members IRS1 and GR (5.0E-26
Author Summary
Protein kinases are enzymes that regulate key cellular
processes by covalently attaching a phosphate group to
substrate proteins; they are crucial components of
signaling pathways involved in cancer, diabetes, and many
other diseases. Identifying the substrates of particular
protein kinases is challenging, and many existing bio-
chemical methods are biased against weakly expressed
proteins like transcription factors. Here we exploited the
observation that mitogen-activated protein kinases
(MAPKs) briefly attach to many of their substrates before
phosphorylating them, docking onto a sequence known as
the ‘D-site’. We developed D-finder, a computational tool
that uses a combination of expert knowledge and machine
learning to search genome databases for D-sites. We then
verified several of D-finder’s predictions using rigorous and
well-established biochemical assays. The most intriguing
predicted and verified substrates were the Gli1 and Gli3
transcription factors of the ‘hedgehog’ signaling pathway.
Gli transcription factors are involved in embryonic
development and stem cell differentiation, and have also
been found to be hyperactive in several types of cancer.
There is emerging evidence that crosstalk with MAPK
pathways is important in Gli-mediated regulation. Our
study, however, is the first to show that MAPKs directly
phosphorylate Gli transcription factors.
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sequences derived from training set members generated scores
ranging from 1E-24 to 1E-36. Note that the closer a Viterbi score
is to 1, the ‘better’ it is (where better scoring sequences presumably
have a higher probability of being a bona fide D-site), yet very good
scores may still be very small numbers; this is standard in HMM-
based approaches [42].
Next, the full-length sequences of the proteins in the training set
were tested. In each case, the HMM was able to identify the
published D-site as the top scoring window within the full-length
polypeptide. Graphs of the scores for successive windows running
from the amino- to the carboxy- terminus in three test proteins are
shown in Fig. 2. The single D-site in MKK4 [32] resulted in a
single peak near the N-terminus of this protein (Fig. 2A).
Moreover, the three known D-sites in the N-terminus of MKK7
[33] resulted in three corresponding peaks in the D-learner.T1
output (Fig. 2B). In contrast, an arbitrarily chosen coding sequence
with no known D-sites has no obvious peaks (Fig. 2C). This
Figure 1. MAP kinases interact with D-sites on substrates and regulators. (A) JNK and several classes of JNK-interacting proteins. The D-site
on JNK-binding proteins is shown as a triangle. (B) Literature-verified JNK D-sites that were used as a training set for the hidden Markov model
component of D-finder. (C) Sequence logo [111] of the central 14 residues of the D-sites shown in B.
doi:10.1371/journal.pcbi.1000908.g001
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PLoS Computational Biology | www.ploscompbiol.org 3 August 2010 | Volume 6 | Issue 8 | e1000908Figure 2. Validation of the D-learner hidden Markov model. (A–C). The HMM accurately identifies known D-sites in full-length sequences. Full-
length sequences run through the HMM give a Viterbi probability for every window tested. The x-axis displays the window number and the y-axis
shows the log of the Viterbi probability for each window. The dashed lines represent the threshold of E-23 for a window to be considered a predicted
D-site. MKK4 (A) has one peak, MKK7 (B) has three peaks, and the arbitrarily-chosen full length sequence SEMA3C (C) has zero peaks above the
threshold. (D) The HMM does not score randomized sequences highly, even if they have the same composition as a high-scoring D-site. Histogram of
scores assigned to 1,000 scrambled sequences with same sequence composition as the MKK4 D-site (blue, left ordinate labels) and the 20 training set
D-site sequences (green, right ordinate labels). Sequences were binned by score, with no sequences scoring below 237 or above 214. For the MKK4
randomized set, zero sequences surpassed the 223 threshold (dashed line). For the 20,000 total randomized D-site sequences, 30 sequences (0.15%)
scored above this threshold. For the training set, 16 sequences (80%) surpassed the E-23 threshold. (E) The HMM scores JNK D-sites higher than D-
sites selective for ERK- or p38-family MAPKs. The name, D-learner-assigned score, and sequence of all known human MKK D-sites are shown. The JNK
D-sites (MKK4 and the 3 MKK7 D-sites) surpass the 223 threshold; however, the non-cognate D-sites, although they contain the core consensus basic
(blue) and hydrophobic (red) residues, do not score above the threshold.
doi:10.1371/journal.pcbi.1000908.g002
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sequences in the translated human transcriptome in which D-
learner.T1 did not find any window with a score above 1E-23 (this
cutoff is represented by the dashed lines Fig. 2A–D).
Third, as a test of the ability of D-learner to identify literature-
verified D-sites that it had not been trained on, a leave-one-out
cross-validation (LOOCV) test was implemented. In this test, each
of the original 20 training set sequences was removed from the
training set one at a time (so that 19 D-sites remained in the
training set), the HMM was retrained, and the removed sequence
(in the context of its full length protein sequence) was used as a test
sequence. In every case, the removed sequence was still the top
scoring window within the full-length polypeptide (data not
shown). It should be noted that the LOOCV test is most stringent
when the left out sequence is not overly similar to the training
sequences, as was true in many but not all of the LOOCV tests we
performed (see Text S1 Fig. 1 for a multiple sequence alignment of
the training set D-sites). We also performed a combinatorial series
of ‘‘leave-four-out’’ cross validation tests. In these tests the ability
of D-finder to identify the bona fide D-sites in the left-out sequences
degraded to 70%. This is evidence that the 20-member training set
is indeed near the minimum required for an effective HMM.
As a fourth test, we assessed the range and distribution of
probabilities that D-learner.T1 assigned to scrambled D-site
sequences. Each of the D-sites in the training set was randomly
permuted 1,000 times and scored by the HMM. Fig. 2D shows the
result obtained when the randomized strings of MKK4 were
binned and plotted. The median of the 20,000 total sequences was
2.5E-30, with a minimum score of 6.2E-37 and a maximum
of 2.2E-19. This can be compared to the scores given to the
unrandomized training set of 20 sequences, which had a median,
minimum and maximum of 6.2E-20, 1.5E-26 and 2.4E-14,
respectively. Thus, D-learner.T1, on average, assigned much
better scores to bona fide D-sites than to scrambled sequences of
the same composition.
Next, we used receiver operating characteristic (ROC) analysis,
which compares how the true positive and false positive rates vary
as the threshold used to discriminate predicted positives from
predicted negatives is varied. As a set of true positives, we used the
training set members. To estimate the false positive rate as a
function of threshold, we ran D-learner.T1 on the predicted
proteomes of the bacteria E. coli and B. subtilis. As bacteria do not
contain MAP kinases, any D-site-like sequences found in these
organisms either occur by chance or have evolved to serve some
other function. In either case, they can be considered false
positives. The results of this analysis are shown in Text S1 Fig. 2.
The area under the curve is 0.92, where 1.0 would be the score of
a perfect classifier, and 0.5 would be the score obtained by flipping
a coin to classify each window. A score of 0.92 thus indicates very
good performance.
Based on these data, we set the threshold for a top scoring
subsequence to be considered a ‘‘high-quality’’ predicted D-site to
1E-23. This threshold represents a compromise between the goals
of (1) including members of the training set while (2) excluding all
but the very tail of the scrambled distribution. The threshold of
1E-23 is a point that only 0.15% (30/20,000) of the scrambled
sequences surpassed, yet 80% (16/20) of the training set members
did. In addition, less than 0.005% (1/30,000) of 19mers randomly
chosen from either the human, E. coli or B. subtilis proteomes
surpassed this threshold. This threshold is represented by the
dashed lines in the graphs in Fig. 2A–D.
As a final assessment of D-learner.T1, we compared the scores it
gave to cognate vs. non-cognate D-sites. MKK4 and MKK7 are
the physiological (cognate) activators of JNK1-3, whereas the
MAPK kinases MEK1/2 and MKK3/6 activate the ERK1/2 and
p38 MAP kinases, respectively, and do not phosphorylate JNK1-3.
Consistent with these strong enzymatic preferences, JNK proteins
bind selectively to MKK4- and MKK7-derived D-sites and do not
bind appreciably to D-sites in other MKKs [31], despite the
observation that all MKK-derived D-sites share the core consensus
basic and w-X-w motifs (Fig. 2E). In accord with these biochemical
results, D-learner.T1 ranked the D-sites in the cognate JNK
kinases MKK4 and MKK7 much higher than those in non-
cognate MAPKs. The cognate MKK4 D-site and all three cognate
MKK7 D-sites had Viterbi scores ranging between 1E-18 to 1E-
20, whereas the non-cognate D-sites in MEK1/2 and MKK3/6
had lower scores ranging between 1E-25 and 1E-27. In addition,
all four cognate D-sites scored well above the cut-off of 1E-23,
whereas all four non-cognate D-sites scored below this cut off.
Thus, the trained hidden Markov model was able to discriminate
JNK-docking sites from docking sites for other MAP kinases.
Development of a hybrid algorithm
To explore the potential utility of D-learner.T1 to predict novel
D-sites from genome-scale information, it was run on the
translated human transcriptome. Examination of the top-ranked
sequences revealed a potential weakness in the D-learner.T1
model: it was giving high-ranking scores to many sequences that
did not contain a canonical w-X-w submotif, and in some cases
also to sequences lacking even a single-residue basic submotif (see
Text S1 Fig. 3). Mutagenesis studies have shown that the basic
submotif, as well as both hydrophobic residues in the w-X-w
submotif, are crucial for D-site function [32]. Therefore, we
concluded that sequences that did not contain a canonical basic or
w-X-w submotif would be enriched for false positives relative to
those that did.
In parallel with the development of D-learner, we also
developed an expert knowledge-based pattern-matching algorithm
that we dubbed D-matcher. The first version of D-matcher
searched for w-X-w submotifs and appropriately-spaced clusters of
basic residues (see Methods). D-matcher performed well in several
validation tests, but produced too many sequences with similar
scores. Also, we believed that there was additional information
contained within D-site sequences that was difficult to incorporate
into a rule-based algorithm. It was therefore deemed unsuitable for
genome-scale screening on its own.
Because neither D-learner nor D-matcher was ideal for
genome-scale screening as separate algorithms, we developed a
hybrid program named D-finder, which incorporates a simplified
D-matcher as a pre-screen for sequences suitable to pass to D-
learner. This program was used for all subsequent analyses.
Transcriptome screening
To identify putative novel JNK-interacting proteins in the
human genome, 33,730 full-length protein sequences, representing
the predicted human translated transcriptome, were scored by D-
finder (Fig. 3A). Overall, 403 proteins contained predicted D-sites
that surpassed our conservative threshold (see Table S1 Table 1),
corresponding to a hit rate of 1.19%. To provide a basis for
comparison, we also ran D-finder on the predicted proteomes of
the bacteria E. coli and B. subtilis, obtaining per protein hit rates of
0.58% and 0.36%, respectively.
The top 25 predicted human D-sites sequences, ranked
according to Viterbi score, are shown in Fig. 3B. Six of the top
seven and ten of the top nineteen are training set members
(colored green in Fig. 3B), indicating that the literature-verified D-
sites were given an appropriately high ranking in the context of a
whole genome search. In general, predicted human D-sites
Predicting MAP Kinase Substrates and Docking Sites
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(median D-site sequence identity 89%, see Table S1 Table 2), in
those cases where orthologs could be readily discerned.
Scansite is a published motif-finding tool that uses a weight
matrix-based scoring algorithm to search for many sequence
motifs, including ERK D-sites [7]. Since ERK D-sites share a core
consensus with JNK D-sites, we compared Scansite to D-finder.
Comparing the highest scoring D-site when each tool was run on
the same sequence revealed that D-finder and Scansite often
prioritized the same site. For example, for the proteins in the
Figure 3. D-finder architecture and results of human genome search. (A) Overview of D-finder. D-finder consists of D-matcher, a pattern
matching algorithm employing expert knowledge, and D-learner.T1, a profile HMM trained on the training set shown in Fig. 1B. D-matcher filters out
most windows, but found many acceptable windows in most sequences. D-learner assigns a probability score to each window it is passed, and found
above-threshold windows in only 403 of the sequences passed to it by D-matcher. When D-learner was run without D-matcher interceding, it found
2,260 above-threshold windows in 1,784 sequences. (B) The top 25 D-sites found by D-finder in the human genome.
doi:10.1371/journal.pcbi.1000908.g003
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65% of the cases. When we compared their performances in
database searches, however, Scansite and D-finder were quite
different. For example, only one of the top 25 predictions from D-
finder was also among the top 25 predictions of Scansite, and only
three of D-finder’s top 25 predictions were in Scansite’s top 500
predictions. Notably, none of the four proteins analyzed in detail
below (hnRNP-K, PPM1J, Gli3 and Gli1) were in Scansite’s top
2000. Thus, Scansite and D-finder prioritize different sequences.
Identification of a D-site in hnRNP-K
The list of predictions generated by D-finder was first scanned
for known JNK substrates or regulators that were not previously
known to contain a D-site. Heterogeneous nuclear ribonucleo-
protein K (hnRNP-K) is an RNA and DNA binding protein that
regulates transcription and translation [58,59], and has been
implicated in the pathology of several types of cancer [60,61]. It is
also a known substrate of several different kinases, including both
JNK and ERK. Although ERK and JNK phosphorylation have
been shown to modulate the regulatory activities of hnRNP-K
[61,62,63], and key MAPK phosphorylation sites on hnRNP-K
have been mapped [62,63], no MAPK-docking sites have
heretofore been identified on hnRNP-K. D-finder assigned a
Viterbi score of 4.5E-22 to a putative D-site (core sequence:
RGGSRARNLPL) that it found at residues 296–310 of hnRNP-
K; overall, this D-site ranked 206 of the 403 above-threshold sites.
A diagram of hnRNP-K with its three RNA/DNA-binding K
homology (KH) domains is shown in Fig. 4A [58]. The predicted
D-site lies within the K-protein-interactive (KI) domain, a region
known to mediate protein-protein interactions with several other
hnRNP-K binding partners [58,64,65,66].
To assess the nature of the interaction between human JNK1
and human hnRNP-K, JNK1 was fused at its N terminus to
Schistosoma japonicum glutathione S-transferase (GST), and the
resulting fusion protein was expressed in bacteria and purified by
adsorption to glutathione-Sepharose beads. JNK1 prepared in this
manner is obtained in its unphosphorylated, unactivated state.
GST-JNK1 (or GST alone as a negative control) was then
incubated with full-length human hnRNP-K that had been
produced in radiolabeled form by in vitro translation (Fig. 4B).
Bead-bound complexes were collected by sedimentation, washed
extensively, and analyzed by SDS-PAGE and autoradiography. As
shown in Fig. 4C, full-length hnRNP-K bound efficiently to JNK1;
this binding was specific, because only trace precipitation of
hnRNP-K occurred when GST was used instead of the GST-
JNK1 fusion protein.
To test the hypothesis that the predicted D-site in hnRNP-K is
important for JNK binding, the ability of wild-type full-length
hnRNP-K to bind to JNK1 was compared to a D-site mutant of
hnRNP-K, in which the critical basic and hydrophobic residues of
the D-site consensus were mutated to alanine (Fig. 4B). As shown
in Fig. 4C, the D-site mutant of hnRNP-K did not bind to JNK1
above background. Thus, the predicted D-site in hnRNP-K
mediates binding to JNK1.
The predicted D-site lies within 100 residues of mapped JNK
and ERK phosphorylation sites in hnRNP-K (Fig. 4A) [57,58].
Having established that this D-site mediated JNK binding to
hnRNP-K, we next wanted to determine if it also facilitated the
phosphorylation of hnRNP-K by JNK at the known JNK target
phosphosite Ser353. To limit the possible phosphoacceptor sites to
Ser353, two N-terminally truncated versions of hnRNP-K, one
with the D-site (w/D, residues 281–464) and one without (w/o D,
residues 317–464), were fused to GST and expressed and purified
from bacteria. These two protein substrates were incubated with
purified active JNK1 and radiolabeled ATP in a standard in vitro
kinase assay (Fig. 4D). Active JNK1 efficiently phosphorylated the
GST-hnRNP-K fragment containing an intact D-site (Fig. 4E). In
contrast, the level of phosphorylation was significantly diminished
(approx 9-fold) for the GST-hnRNP-K fragment lacking the D-
site. GST alone was not phosphorylated by any of the active
MAPK enzymes used in this work (data not shown).
Because hnRNP-K is also a substrate of ERK2, we tested the
ability of ERK2 to bind to and phosphorylate hnRNP-K in a D-
site-dependent manner. GST-ERK2 bound to hnRNP-K, and the
strength this interaction was reduced about 3-fold by mutation of
the D-site (data not shown). In addition, active ERK2 phosphor-
ylated the GST-hnRNP-K fragment, and the extent of phosphor-
ylation was slightly reduced by removal of the D-site (data not
shown). The simplest explanation of these results is that ERK2
utilizes the predicted D-site, but that there is also an additional
docking site for ERK somewhere within hnRNP-K residues 281–
464. This would not be surprising, as many MAPK substrates and
regulators have been shown to contain multiple MAPK-docking
sites [33,54,67]. A second possibility is that ERK2 phosphorylation
of Ser353 is largely independent of ERK2-hnRNP-K docking. We
did not examine whether the D-site promoted ERK-mediated
phosphorylation of Ser284 or JNK-mediated phosphorylation of
Ser216.
To summarize, D-finder predicted a novel D-site in the known
JNK substrate hnRNP-K; this D-site was found to be a bona fide D-
site that mediated JNK-hnRNP-K binding and promoted JNK-
dependent phosphorylation of Ser353 in hnRNP-K.
Identification of a D-site in PPM1J/PP2Czeta
PP2Czeta, also known as PPM1J, is type 2C protein
phosphatase that is enriched in testicular germ cells [68]. PPM1J
is a recently identified JNK substrate; JNK phosphorylates PPM1J
on Ser92 and Thr205, and more weakly on Thr202. Moreover,
JNK phosphorylation of Ser 92 of PPM1J reduces its phosphatase
activity [69]. No MAPK-docking sites have been reported in
PPM1J. D-finder assigned a Viterbi score of 2.7E-22 to a putative
D-site (core sequence: RPTFLQL) that it found in residues 68–74;
overall, this D-site was rank 256 of the 403 above-threshold sites.
To test the ability of this D-site to mediate the binding of PPM1J
to JNK in vitro, JNK binding to wild-type GST-PPM1J was
compared with binding to a PPM1J N-terminal deletion mutant
lacking the putative D-site (Fig. 5A). As shown in Fig. 5B,
radiolabeled JNK1, JNK2 and JNK3 all bound to wild-type
PPM1J but not to GST alone. In comparison, the binding of all
three JNK proteins to the PPM1J derivative lacking the D-site was
substantially reduced.
To determine if the novel D-site promoted the phosphorylation
of PPM1J by JNK, the GST-fused wild-type PPM1J protein and a
GST-fused D-site point mutant derivative (DSM) were incubated
with active JNK1, JNK2, and JNK3 and radioactive ATP in a
standard kinase assay (Fig. 5C). The results of these assays (Fig. 5D)
show a significant reduction in phosphorylation of the D-site
mutant protein relative to the wild type, at two different
concentrations for each of the three JNK enzymes.
As an alternative means to assess D-site-mediated phosphory-
lation of PPM1J by JNK, V5-epitope-tagged versions of the wild-
type and D-site point mutant of PPM1J were expressed in Cos-1
cells and immunoprecipitated with an anti-V5 antibody. Immu-
noprecipitates were then mixed with purified active JNK1 and
radioactive ATP (Fig. 5E). As shown in Fig. 5F, under these
conditions wild-type PPM1J was phosphorylated while the D-site-
mutant PPM1J was not.
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JNK substrate PPM1J; this was found to be a bona fide D-site
promoting JNK binding and JNK-mediated phosphorylation.
Verification of novel candidates by peptide array
To begin to weed through the novel D-finder predictions
resulting from the transcriptome search, a peptide array approach
was employed. Peptide arrays are macro arrays of short peptides
that are tethered to a nitrocellulose membrane via a chemical linker
attached to theirC-termini[70].Peptides(17-mers)representingthe
training set members, as well as 59 of the predicted novel D-sites,
were arrayed in duplicate and probed for binding to radiolabeled
JNK1 (Fig. 6A, 6B, see also Table 3 in Table S1). Each array
contained two positive control peptides (MKK4 and MKK7-D2,
where MKK7-D2 is the second of the three D-sites in the N-
terminal domain of MKK7 [33]) and two negative control peptides
(D-site mutants of MKK4 and MKK7-D2, in which the critical
basic and hydrophobic residues of the D-site consensus were
Figure 4. Identification of a D-site in the known JNK substrate hnRNP-K. (A) Full-length hnRNP-K protein. KH, K homology domain; KI, K
interaction domain. The positions of known JNK and ERK phosphosites and the D-finder-predicted D-site are shown, with key consensus basic (blue)
and hydrophobic (red) residues highlighted by color. (B) Wild-type (WT) and D-site mutant versions (DSM) of hnRNP-K were tested for binding to GST-
JNK1. The sequence of the D-site mutant is shown. (C) As shown in B,
35S-radiolabeled full-length hnRNP-K protein and a D-site mutant derivative
were prepared by in vitro translation and partially purified by ammonium sulfate precipitation, and portions (5% of the amount added in the binding
reactions) were resolved on a 10% SDS-polyacrylamide gel (lane 1). Samples (,1 pmol) of the same proteins were incubated with 40 mg of GST (lane
2) or with 10 to 40 mg of GST-JNK1 (lanes 3–6), bound to glutathione-Sepharose beads, and the resulting bead-bound protein complexes were
isolated by sedimentation and resolved by 10% SDS-PAGE on the same gel. The gel was analyzed by staining with Coomassie Blue (CB) for
visualization of the bound GST fusion protein (a representative example is shown in the lowest panel) and by Phosphorimager analysis for
visualization of the bound radiolabeled protein (upper two panels). (D) Fragments of hnRNP-K were tested as substrates for in vitro phosphorylation
by active JNK. (E) As shown in D, GST fusions to hnRNP-K281–464 (containing the D-site, w/D) and hnRNP-K317–464 (deleted of the D-site, w/o D) were
purified and incubated with purified active JNK1 and [c-
32]ATP for 20 min. Substrate concentration: 500 nM; Enzyme activity: 0, 0.8 mU, or 8mU.
Reaction products were separated by SDS-PAGE and incorporation of radioactive phosphate into the substrate was assessed on a PhosphorImager.
doi:10.1371/journal.pcbi.1000908.g004
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arrayed peptides was quantified with a PhosphorImager and
normalized to the signal obtained with the MKK7-D2 positive
control. MKK7-D2waschosen as a normalizationbase because itis
known to exhibit real, but relatively weak, binding [33], and gave a
correspondingly weak signal in the peptide array assay (Fig. 6B).
Thus, we judged that any D-site peptide giving a lower binding
signal than MKK7-D2 was probably not worth pursuing.
Figure 5. Identification of a D-site in the PPM1J phosphatase. (A) Wild-type (WT) and N-terminal truncated versions (NT w/o D) of PPM1J were
fused to GST and tested for binding to JNK 1–3. The sequence of the D-site is shown. (B) As shown in A,
35S-radiolabeled JNK1, 2 or 3 (,1 pmole)
were tested for binding to 40 mg of GST (lane 1) or 30 mg of GST-PPMIJ K17–506 (containing the D-site, lanes 3 and 4) or GST-PPMIJ K80–506 (lacking the
D-site, lanes 5 and 6). Lane 1 shows a 5% of the total JNK input. The lower panel shows Coomassie Blue (CB) staining of the sedimented GST-fusion
proteins. Other details as in Fig. 4C. (C) Wild-type (WT) and D-site-mutant (DSM) versions of PPM1J were tested as substrates for in vitro
phosphorylation by active JNK1-3. (D) As shown in C, 1 mM of each GST-PPM1J protein was incubated with 0, 0.1 or 1 mU JNK1-3 and [c-
32]ATP for
20 min. Incorporation of radioactive phosphate into the substrate, as assessed by autoradiography, is shown in 3 panels, and a representative
Coomassie blue (CB) stained gel, to demonstrate equal loading of the substrates proteins, is shown. (E) Wild-type and D-site mutant versions of
PPM1J were C-terminally-tagged with the V5 epitope, expressed in Cos-1 cells, immunoprecipitated, and used as substrates for JNK1-mediated
phosphorylation. (F). As shown in E, Cos-1 cells were transfected with either empty vecor (EV), PPM1J-V5 WT, or PPM1J-V5 DSM. 16 h post-
transfection, the cells were harvested, lysed, and immunoprecipitated with anti-V5 antibodies. MAPK buffer, [c-
32]ATP, and active JNK1 were added to
the immunoprecipitated pellets, and phosphorylation of the immunoprecipitated proteins was visualized by PhosphorImager. In addition, portions
(20 mg) of each lysate were separated by SDS-PAGE and immunoblotted (WB, for Western Blot) with either anti-V5 (1:5000) or anti-total JNK (1:500)
antibodies.
doi:10.1371/journal.pcbi.1000908.g005
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PLoS Computational Biology | www.ploscompbiol.org 9 August 2010 | Volume 6 | Issue 8 | e1000908Figure 6. Testing predicted D-sites with peptide arrays. (A) Membrane-attached peptides were probed for binding to radioactively-labeled
JNK1. Peptides containing functional JNK-docking sites (e.g. the MKK4 or MKK7-D2 positive controls or accurate predictions) bound to JNK1, while
those containing non-binding peptides (e.g. negative controls or false predicitions) did not. (B) Representative examples of peptide arrays probed
with
35S-labeled JNK1 and then visualized and quantified by Phosphorimager. Controls (circled, in duplicate on each membrane) are the published D-
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Fig. 6B. The results of these experiments highlight the utility of this
approach. First, duplicate spots on the array exhibited similar
levels JNK1 binding (e.g., see control peptides, circled). Moreover,
comparable results were obtained when the same peptide
sequences were probed on different arrays on different days
(compare control peptides between top and bottom arrays). The
MKK4 and MKK7-D2 peptides both exhibited reproducible
positive signals on the arrays, with the MKK4 peptide binding
more efficiently, consistent with its lower Kd [33]. As anticipated,
the D-site mutant negative control peptides exhibited barely
detectable binding. Finally, the other members of the training set
bound almost as efficiently, on average, as the MKK4 D-site.
Thus, the peptide array methodology appeared to provide
reproducible and quantitative data on the binding of MAPKs to
D-site peptides. Furthermore, signal strength roughly correlated
with binding affinities measured by other methods. These
conclusions are consistent with our previous experiences using
this approach [32,71,72].
Fig. 6C shows the normalized JNK binding of 59 high scoring
D-finder-predicted D-sites (see Fig. 3B for scores of top 25
predictions and Table 3 in Table S1 for further annotation). These
peptides correspond to novel D-finder predictions and are not
members of the training set. Of these 59 peptides, 45 bound to
JNK1 at a level that was greater than MKK7-D2, our cutoff for
weak-yet-real binding. Thus, the predictive accuracy of D-finder
was ,76% (45/59). From these results it can be concluded that the
D-finder algorithm is effective at discovering novel peptides that
have the ability to bind to JNK.
Gli3 is a MAPK substrate
Selected candidates that gave a positive binding signal on the
peptide array were chosen for further analysis. We first focused on
the zinc-finger transcription factor GLI-Kruppel Family Member
3 (GLI3), which contained a D-site that was ranked 4th overall by
D-finder, the highest scoring prediction that was not a member of
the training set (see Fig. 3B). This D-site (core sequence:
RKRTLSI) comprises residues 290–296 of the 1580 residue Gli3
protein. A peptide version of this D-site bound to JNK1 at 193%
the level of the MKK7-D2 positive control in the array assay.
GLI3 encodes a transcription factor in the hedgehog signaling
pathway, and is homologous to the Drosophila gene/protein cubitus
interruptus (Ci) [73,74]. Germ line mutations in GLI3 have been
implicated in two human developmental disorders: Pallister-Hall
syndrome and Grieg cephalopolysyndactyly syndrome [75].
Furthermore, several recent studies strongly suggest the possibility
of crosstalk between MAPK signaling and hedgehog signaling, but
the molecular basis for this crosstalk remains to be identified
[76,77,78,79,80,81,82]. For all these reasons, Gli3 protein was
chosen for further analysis.
As large proteins often exhibit non-specific binding in pull-down
assays, we constructed a fragment consisting of amino acids 280–
478, stretching from the D-site to just before the beginning of the
five kruppel zinc-finger domains (Fig. 7A, bottom panel). At the
same time, we constructed a D-site mutant version of this protein
(DSM), changing the key basic and hydrophobic residues in the D-
site to alanine (Fig. 7A). Both versions were produced by in vitro
transcription/translation and assessed for binding to GST-fused
JNK1, JNK2 and JNK3. As shown in Fig. 7B and 7C, the wild-
type protein fragment bound well to all three JNK paralogs, with a
slight preference for JNK2 over JNK1/3. In contrast, the D-site
mutant exhibited greatly decreased binding to all three JNK
proteins. Thus the D-site in Gli3 binds to JNKs as predicted.
Although D-finder was trained with JNK docking sites and
showed an ability to discriminate JNK D-sites from ERK and p38
D-sites (see Fig. 2E), several of the D-sites in the training set are
known to bind to ERK as well as JNK, e.g. the Elk-1 D-site [45].
Therefore, wild-type and D-site mutant Gli3 were tested for
binding to ERK2. Indeed, Gli3 also bound ERK, while the D-site
mutant did not (Fig. 7B, 7C).
We hypothesized that the newly identified D-site might promote
the MAPK-mediated phosphorylation of Gli3. To test this
possibility, GST-Gli3280–478 WT and DSM proteins were purified
and used as substrates for in vitro kinase assays with purified
activated MAPKs. As shown in Fig. 7D and 7E, wild-type Gli3
was an efficient substrate for all 3 MAPKs tested (JNK1, JNK2
and ERK2), whereas the D-site mutant exhibited greatly reduced
phosphorylation. Thus the D-site promotes MAPK-mediated
phosphorylation of Gli3.
Identification of a target phosphosite for JNK on Gli3
Within the Gli3280–478 fragment, there are five possible MAPK
target phosphosites (S/T-P; Fig. 8A). To identify site(s) phosphor-
ylated by JNKs in a D-site-promoted manner, we used tandem
mass spectrometry to compare the phosphorylation of four
different samples, consisting of the wild-type and D-site mutant
versions of Gli3280–478, incubated either with or without active
JNK2 and ATP. Following real or mock phosphorylation
reactions, the products were separated by SDS-PAGE, digested
with chymotrypsin, and analyzed by LC MS/MS. MS/MS
analysis of the wild-type sample in the presence of kinase identified
a phosphopeptide (MH2
2+ 851.40) with a sequence of GHLSA-
SAI(pS)PALSFTY (Fig. 8B). As shown in the MS/MS spectrum
(Fig. 8B), the fragment ion (MH2
2+ 802.50) derived from the
parent ion with a loss of H3PO4 was observed, indicating that this
peptide is phosphorylated. The detection of a series of y ions (i.e.,
y2,y11) and b ions (i.e., b3,b 5–b8,b 11–b15) identified the peptide
sequence unambiguously. In order to compare the identified
phosphorylation in the four different samples, extracted ion
chromatograms of the phosphorylated peptide (MH2
2+ 851.40)
were obtained and compared as shown in Fig. 8C. A prominent
peak, eluting at around 38 minutes, is present in the phosphor-
ylated wild-type sample, diminished in phosphorylated D-site-
mutant sample, and absent in the unphosphorylated control
samples. The mass spectra of this peak at the given elution time
(Fig. 8D) further demonstrated that the identified phosphopeptide
(MH2
2+ 851.40) was only present in the samples with kinase and
absent in the no kinase controls. Taken together, these results
suggested that phosphorylation of Ser343 in the GST-Gli3280–478
protein was mediated by the D-site.
To validate the mass spectrometry results, we used site-directed
mutagenesis to change Ser343 to alanine and repeated the in vitro
kinase assay with active JNK1, JNK2, and JNK3. The result of this
assay (Fig. 8E) showed a reduction in phosphorylation of the
GST-Gli3280–478 S343A protein to the low levels seen with the
D-site mutant protein, confirming the mass spectrometry results.
sites of MKK4 and MKK7-D2, and their mutants with alanine substitutions at the critical basic and hydrophobic residues. The binding efficiency of the
average of the training set peptides and the positive and negative controls are plotted; this has been normalized by setting the efficiency of the
MKK7-D2 positive control to 100%. (C) Plot of the normalized binding percentages (with S.E.M. bars) for the 59 predicted D-site peptides that were
tested. The threshold for classification as positive is 100%. Red-colored bars are above threshold, green-colored bars are below threshold.
doi:10.1371/journal.pcbi.1000908.g006
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tion in the S343A mutant. This could indicate that there is at least
one additional authentic target residue in this region (and that the
phosphorylation of this residue(s) is not strongly dependent on the
integrity of the D-site). Alternatively, it is possible that removal of
the D-site leads to non-authentic phosphorylation of cryptic sites,
as has been observed with the JNK substrate c-Jun [18]. These
possibilities are currently under investigation.
Figure 7. Gli3 is a novel MAP kinase substrate with a functional D-site. (A) Diagram of full length Gli3, shown with its transcriptional
repressor domain (Rep Dom, purple rectangle), the Suppressor-of-Fused binding site (SuFu BS, green rectangle), and its 5 Zinc Finger (ZF) DNA-
binding domains (gray oval). The position (triangle) and sequence of the D-finder-predicted D-site is also shown. Below, the Gli3280–478 wild-type (WT)
and D-site mutant (DSM) fragments used for binding and kinase assays are shown, along with the sequence of the D-site mutant. (B) The Gli3280–478
wild-type and D-site mutant proteins were tested for binding to GST, GST-JNK1, GST-JNK2, GST-JNK3, and GST-ERK2 (40, 30, 30, 20 and 30 mg
respectively). The upper two panels show the bound Gli3 derivatives, with 5% if the total input shown in lane 1; the lower panel shows Coomassie
Blue (CB) staining of the sedimented GST-fusion proteins. Other details as in Fig. 4C. (C) Graph of the results of three independent repetitions of the
binding assay shown in A and B, with duplicate points in each repetition. Standard error bars are shown (n=3). (D) In vitro kinase assays assessing the
phosphorylation of the WT and DSM fragments of Gli3 by active JNK1 and JNK2. Three separate concentrations of substrate (0.1, 0.3 and 0.5 mM) were
incubated with 0.5 mU (,1 ng) of active enzyme. Image is representative of three independent experiments. Other details as in Fig. 4E. (E) In vitro
kinase assay assessing the phosphorylation of the WT and DSM fragments of Gli3 by activated ERK2. Substrate concentration: 0.5 mM. Enzyme activity:
ERK2 – 0, 1, or 10 units (10 units is ,1 ng).
doi:10.1371/journal.pcbi.1000908.g007
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PLoS Computational Biology | www.ploscompbiol.org 12 August 2010 | Volume 6 | Issue 8 | e1000908Figure 8. D-site-directed phosphorylation of Gli3 Ser343. (A) There are five putative MAPK target sites in the portion of Gli3 protein found to
be phosphorylated in this work. To determine which sites were phosphorylated, Gli3 was incubated with active JNK2. (B), (C) & (D). Mass spectrometry
analysis of an identified phosphorylated peptide (m/z 851.40, GHLSASAIS(phospho)PALSFTY). Four samples were analyzed: WT Gli3 with active kinase,
DSM with active kinase, WT with no kinase, and DSM with no kinase. (B) MS/MS spectra of the identified peptide in the GST-GLI3280–478 WT plus active
kinase sample. bi*=[bi2H3PO4]; yi*=[yi2H3PO4]. (C) Extracted ion chromatograms (XIC) of the parent ion from the four samples during LC MS runs.
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Gli3280–478 was also reduced compared to the wild type; however,
it was not reduced all the way down to the level seen with the D-
site mutant (data not shown). This suggests that Erk2 phosphor-
ylates Ser343 and at least one additional residue in a D-site
dependent manner.
To summarize, we have identified Gli3 as a novel substrate of
JNK and ERK. The predicted D-site mediates binding of Gli3280–
478 to MAPKs, and also promotes the JNK-mediated phosphor-
ylation of Ser343, as well as the ERK-mediated phosphorylation of
both S343 and an additional target site(s).
Gli1 is also a MAPK substrate
Gli3 is one of three mammalian homologues of the Drosophila
transcription factor Ci [83]. Gli1, the founding member, was
initially identified as being highly amplified in gliomas, and Gli2
and Gli3 were subsequently cloned by hybridization [83]. A D-site
in Gli2 was identified by D-finder as having a high-ranking score
(3E-22, rank 234 of 403), while the D-site in Gli1 received a score
of 2E-24, not far below our cutoff of 1E-23. The three Gli proteins
contain regions/domains of homology with each other, separated
by stretches of divergence [84]. Notably, the putative D-sites in all
three proteins reside in a conserved region (Fig. 9A), and share
extensive sequence similarity, particularly among the key basic and
hydrophobic residues.
Although all three Gli proteins are implicated in stem cell
biology, development and disease pathogenesis [85,86], evidence
suggestive of crosstalk with MAPK signaling is especially enticing
for Gli1 [76,77,78,79,80,81,82], particularly in relation to a role in
tumorigenesis and cancer progression [87,88]. Thus, to study the
role of the putative Gli1 D-site in MAPK-mediated transactions,
we produced wild-type and D-site-mutant fragments correspond-
ing to the fragments we generated for Gli3. These polypeptides
run from the putative D-site to just before the start of the zinc
finger domain repeats (residues 68–232, Fig. 9B). As shown in
Fig. 9C, wild-type Gli168–232 bound to all MAPKs tested (JNK1-3
and ERK2), and bound particularly well to JNK3 and ERK2. In
addition, the D-site-mutant of Gli168–232 exhibited substantially
impaired binding (Fig. 9C) to MAPKs. When incubated with
active JNK1, JNK2, JNK3 or ERK2, wild-type GST-Gli168–232
was phosphorylated with high efficiency, whereas the D-site
mutant of the Gli1 fragment was phosphorylated to a much lower
extent (Fig. 9D). These data indicate that the conserved D-site in
Gli1 promotes binding and phosphorylation by JNKs and ERK2.
As detailed in the previous section, our mass spectrometry and
mutagenesis analysis revealed that Ser343 of Gli3 was phosphor-
ylated by JNKs. This region of Gli3 is conserved in Gli1 (and
Gli2), and Ser343 in Gli3 aligns with Ser130 in Gli1 (see Fig. 9A
and also Fig. 4 in Text S1). Thus it seemed reasonable to
hypothesize that Ser130 in Gli1 might be a target for MAPK-
mediated phosphorylation. To test this possibility, an S130A
mutant of Gli168–232 was constructed, purified, and incubated with
active MAPK enzymes and ATP in kinase assays. Fig. 9E shows
that for JNK1, JNK2 and JNK3-mediated phosphorylation,
removal of Ser130 in Gli1 resulted in a reduction of phosphate
incorporation down to the low levels seen in the D-site mutant.
This result indicates that Ser130 is the major target phosphosite
for D-site-directed JNK phosphorylation of Gli168–232.
Similar to the results seen with ERK2 phosphorylation of Gli3
S243A, there was considerable ERK-mediated phosphorylation of
GST-Gli168–232 even when Ser130 was mutated to alanine. This
contrasts with the substantial reduction in ERK-mediated
phosphorylation seen with the D-site mutant of Gli1. Thus, the
D-site in Gli1 must primarily direct ERK2 to target residue(s)
other than Ser130. Indeed, there are six other SP sites in
Gli168–232 that could be ERK target phosphosites.
To summarize, we have identified Gli1 as a novel substrate of
JNK and ERK. JNK phosphorylation of Ser130 in Gli1 is
mediated by the predicted and experimentally verified D-site;
however, this same D-site directs ERK2 to phosphorylate a
distinct target site(s) in Gli1.
Biochemical validation of additional selected candidates
Other candidates that gave a positive binding signal on the
peptide array were also tested in binding assays. The histone-lysine
N-methyltransferase Mixed Lineage Leukemia 4 (MLL4), a 2715-
residue transcriptional regulator that is a potential oncogene [89],
had a predicted D-site ranked number 15 overall by D-finder, and
displayed 161% normalized binding on the peptide array. Two C-
terminal fragments of this protein, one with, and one without, the
putative D-site were constructed (see Fig. 5A in Text S1). In
binding assays (see Fig. 5B in Text S1) the wild-type fragment
bound to JNK1 and JNK2, while the fragment lacking the D-site
did not. As the region near the D-site was devoid of potential
MAPK phosphosites, further analysis of MLL4 was not pursued.
A putative D-site in Nei endonuclease VIII-like 1 (Neil1), a 390
amino acid protein involved in DNA repair [90], was ranked
number 8 overall by D-finder, and bound at 198% of the level of
the MKK7-D2 positive control on the peptide array. As shown in
Fig. 5C and D in Text S1, full-length Neil1 protein bound to GST-
JNK1, but not to JNK2, while the corresponding D-site mutant
bound to neither JNK1 nor JNK2. Neil1, however, was not an
efficient substrate for JNK-mediated phosphorylation (data not
shown).
There were other cases where the predicted D-site had no
apparent effect on the larger protein’s ability to bind to JNK. In
several cases the larger protein did not bind to JNK (or exhibited
barely detectable binding) even though the predicted D-site
peptide did bind to JNK in the peptide array assay. These cases
included ARG1 (see Figs. 5E, F in Text S1), PIK3R1, SH3RF1/
POSH, FARP2, PKD1, and WNK1 (data not shown). A possible
explanation for this class of results is that the predicted D-site was
either buried or locked into position in the native structure and
thus not available for MAPK binding. In other cases, the full-
length protein bound to JNK, but this binding was not strongly
affected by mutation of the predicted D-site (e.g. PIF1, IRGQ,
H6PD, PLEKHA6, LAG3, DLEC1, CNKSR, NR4A, MIB2, data
not shown). In total, 21 proteins were given full biochemical
workup to the point of being tested in binding assays. Six of these
21 (hnRNP-K, PPM1J, Gli3, Gli1, MLL4 and Neil1) exhibited D-
site dependent binding, and for the first 4 of these 6 we found
strong evidence of D-site-dependent phosphorylation. For 15 of
the 21 biochemically-tested proteins (,70%), in contrast, we were
unable to find evidence that the predicted D-site was strongly
functional for binding in the context of the native polypeptide. In
at least some of these cases, it is possible that the predicted D-site is
redundant with other docking sites in the same polypeptide, or
(D) MS of parent ion. (E) Results of an in vitro kinase assay assessing the phosphorylation of the WT, S343A, and DSM fragments of GLI3280–478 by
activated JNK1, JNK2 and JNK3. Image is representative of three separate trials. The Coomassie Blue stained panels demonstrate equal loading of
substrates. Substrate concentration: 1 mM. Enzyme activity: 0, 0.2, or 1 mU.
doi:10.1371/journal.pcbi.1000908.g008
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PLoS Computational Biology | www.ploscompbiol.org 14 August 2010 | Volume 6 | Issue 8 | e1000908Figure 9. Gli1 is a novel MAP kinase substrate with a functional D-site. (A) Sequence alignment of Gli1 and 2 with Gli3 in the regions around
the validated D-site (282–301 in Gli3) and target phosphosite (Ser 343 in Gli3). (B) Diagram of full length Gli1, shown with its Suppressor-of-Fused
binding site (SuFu BS, green rectangle), and its 5 Zinc Finger (ZF) DNA-binding domains (gray oval). The position (triangle) and sequence of the D-
finder-predicted D-site is also shown. Below, the Gli168–232 wild-type (WT) and D-site mutant (DSM) fragments used for binding and kinase assays are
shown. (C) The Gli168–232 wild-type and D-site mutant proteins were tested for binding to GST, GST-JNK1, GST-JNK2, GST-JNK3, and GST-ERK2 (40, 30,
30, 20 and 30 mg respectively). The upper two panels show the bound Gli1 derivatives, with 5% if the total input shown in lane 1; the lower panel
shows Coomassie Blue (CB) staining of the sedimented GST-fusion proteins. Other details as in Fig. 4C. (D) In vitro kinase assays assessing the
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than in a binding assay.
Discussion
Currently, substantial progress is being made in the computa-
tional and functional genomic investigation of the phosphopro-
teome [11,91,92,93]. However, considering that in humans about
500 protein kinases must phosphorylate over 6000 proteins on
multiple sites, it is clear that much still remains to be learned. Here
we have developed D-finder, a computational tool that uses a
hybrid pattern matching/hidden Markov model algorithm to
search protein sequences for kinase-substrate docking sites. The
first version of D-finder focuses on docking sites for the JNK family
of mitogen-activated protein kinases. Using this tool, we identified
previously undiscovered D-sites in the known JNK substrates
hnRNP-K and PPM1J. We also identified functional D-sites in the
DNA repair protein Neil1, and near the C-terminus of the histone-
lysine N-methyltransferase MLL4. Finally, we identified the
hedgehog pathway transcription factors Gli1 and Gli3 as novel,
D-site-dependent JNK and ERK substrates. The latter observa-
tions, if verified in vivo, could be important for understanding
crosstalk and integration between MAPK and hedgehog pathways
in stem cell biology, development and cancer.
D-finder
Accurate computational prediction of protein kinase target
phosphorylation sites (phosphosites) is limited by the short length
and consequent degeneracy of these sites. Nevertheless, predictions
based on phosphosite specificity have been successful for some
kinases (e.g. [9,10,11]). For other kinases, however, such as MAP
kinases, this approach has not been as fruitful. Here we have
attempted to leverage the observation that several important
families of kinases, including MAPKs, tether or dock themselves to
their substrates prior to phosphorylating them [13,14,15,16,17].
These docking interactions are mediated by docking motifs on
substrates that, while still relatively short, potentially contain more
information then phosphosites. We employed a profile hidden
Markov model –a data-driven machine learning approach– to
infer as much information as possible from a training set of
literature-verified docking sites. Although this model (D-learner)
performed well in multiple validation tests, when run on the
human genome, it made many high-ranking predictions that were
inconsistent with expert knowledge of D-site structure/function
that had been gleaned from site-directed mutagenesis studies. To
ameliorate this problem, D-matcher, a simple pattern-matching
scheme, was added as a pre-screen to find peptides suitable to pass
to D-learner. This addition was computationally trivial, yet quite
effective, judging on the ability of the resulting hybrid procedure,
D-finder, to predict binding peptides (see below). More elaborate
hybrid HMM approaches have been applied to other sequence
analysis tasks, e.g. hybrid HMM/neural networks [94,95].
When run on the translated human transcriptome, D-finder
found 403 above-threshold D-sites, about 8-fold the number that
would be predicted by chance. Based on the peptide array assay
(Fig. 6), D-finder was remarkably adept at identifying bona fide
docking site peptides: about 3/4 of the D-finder-predicted peptides
we tested bound to JNK1 at a level that exceeded the binding of
the known D-site MKK7-D2. Of course, just because a given
sequence can bind to JNK as a peptide, this does not necessarily
imply that it will bind in the context of the native protein. Indeed,
when worked up to the level of binding assays, ,30% of candidates
tested were found to bind to one or more of the JNK proteins in a
D-site-dependent manner. It should be noted that D-site-
dependent binding is a relatively stringent assay for D-site
functionality; D-sites with very low affinity in binding assays can
still effectively direct MAPKs to phosphorylate particular target
residues (our unpublished observations). In addition, two or more
docking sites can function redundantly with each other; thus the
functionality of a particular docking site may be missed.
Nevertheless, taking the numbers at face value, as 3 of 4 predictions
passed the peptide array test, and roughly 30% of these passed full
biochemical workup, it can be estimated that about 1 in 5 of D-
finder’s predictions are true positives. This may well be an
underestimate of the true positive rate for reasons given above.
In future modifications, D-finder could be improved in several
ways. First and most obvious, new members could be added to the
training set, including the novel D-sites identified in this work.
Second, the D-matcher front end could be improved by the
addition of further expert knowledge gleaned from additional
mutagenesis studies. Third, the possibility of using additional
information, such as predicted surface accessibility, intrinsic
disorder and evolutionary conservation, could be explored
[96,97]. Finally, the algorithm could be modified to search for
docking sites that are near to a putative phosphosite or to a cluster
of phosphosites [98]. In addition, ERK and p38-targeted versions
of D-finder could be created. MAPK docking sites are found in
diverse members of the plant and animal kingdom, and have
proven to be structurally and functionally conserved from yeast to
humans [99]; thus D-finder could be profitably run on additional
genomes.
A D-site in hnRNP-K
D-finder identified a previously unknown D-site in heteroge-
neous nuclear ribonucleoprotein K (hnRNP-K), a transcriptional
and translational regulator and known JNK/ERK substrate
that is dysregulated in both colon cancer and leukemia
[58,59,60,61,62,63]. We showed that this D-site mediated both
JNK binding and JNK-mediated phosphorylation of Ser384
(Fig. 4). Interestingly, this newly identified D-site lies within the
K-protein-interactive (KI) domain, a region known to mediate
protein-protein interactions between hnRNP-K and Src family
kinases, PKCdelta, WASP, transcription factors, and other
partners [58,64,65,66]. Indeed, the D-site overlaps with SH3-
binding site P3 (RARNLPLPPPPPPRGG), known to interact with
c-Src and Vav [100], and contains Ser302, a target site of
PKCdelta [65]. These considerations suggest that: (1) JNK may
compete with other partners for binding to hnRNP-K; (2) hnRNP-
K may serve as a scaffold to facilitate JNK-mediated phosphor-
ylation of other hnRNP-K binding partners; (3) PKC-mediated
phosphorylation of Ser302 may regulate JNK docking. ERK was
also found to utilize the newly identified docking site, although
mutation of the D-site did not strongly affect ERK-mediated
phosphorylation of Ser384.
Gli1 and Gli3 are MAPK substrates
Gli3, a transcription factor in the hedgehog pathway that is
mutated in human developmental disorders [75], contained the
phosphorylation of the WT and DSM fragments of Gli1 by active JNK1, JNK2, JNK3 and ERK2. Three separate concentrations of substrate (0.1, 0.3 and
0.5 mM) were incubated with the indicated units of active enzyme. Image is representative of three independent experiments. Other details as in
Fig. 4E. (E) As in D, but with the addition of the S130A mutant of Gli1.
doi:10.1371/journal.pcbi.1000908.g009
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we found that this D-site (located in residues 281–300 of Gli3)
mediated binding to JNK1-3 and ERK2. In addition, we showed
that the 281–300 D-site promoted JNK- and ERK-mediated
phosphorylation of target site(s) within Gli3 residues 280–478.
Finally, using mass spectrometry, we identified Ser343 as a
prominent JNK phosphosite, and showed that JNK-mediated
phosphorylation of this site was dependent on the integrity of the
novel D-site.
D-finder also pinpointed highly similar D-sites in the paralogous
transcription factors Gli1 and Gli2, proteins that (like Gli3) are
important in regulators of stem cells and development, and which
are dysregulated in several types of cancer [83,85,86]. Examining
Gli1, we found that the homologous D-site (located within residues
72–91 of Gli1) mediated the binding of JNK1-3 and ERK2 to
Gli1. Further, we showed that this D-site promoted JNK- and
ERK-mediated phosphorylation of target site(s) within Gli1
residues 68–232, and that Ser130 (homologous to Ser343 in
Gli3) was a D-site-dependent JNK phosphosite.
Evidence for MAPK-Gli connection
There has been surprisingly little evidence for integration
between the hedgehog and MAP kinase pathways, two of the
major signaling pathways controlling early development [101].
Recently, however, several papers have provided evidence for such
a connection, particularly in cancer (reviewed in [87,88]).
Typically, these studies have employed both MAPK pathway
activation (using ligands such as epidermal growth factor or
fibroblast growth factor, or using constitutively active Ras or
MEK) and pharmacological inhibition to document effects on
hedgehog pathway readouts such as Gli-dependent transcription,
cell differentiation and proliferation [76,77,78,79,81,82,102,103].
For example, Kessaris et al. found that hedgehog-stimulated
differentiation of oligodendrocite progenitors required ERK
activation [102]. Using a tissue culture model of basal cell
carcinoma, Schnidar et al. [78] found that activation of the
MEK1/2RERK1/2 pathway synergized with Gli1 to transform
cells. Other cancer types where MAPK/Gli crosstalk has been
implicated in pathogenesis include medulloblastoma [103], gastric
cancer [79], melanoma [82], and pancreatic cancer [81]. Indeed,
Hanahan and colleagues have recently proposed that in pancreatic
cancer, non-canonical RAS-mediated activation of Gli proteins is
the primary mechanism of tumorigenesis [80].
Most of the above studies provide evidence for ERK
involvement in Gli regulation, but do not exclude the possibility
of JNK involvement as well. Positive evidence for crosstalk/
integration between Gli transcription factors and the JNK MAP
kinases is less extensive at present. Fogarty et al. [103] showed that
fibroblast growth factor blocked sonic hedgehog signaling in
neural precursor cells. This ability of FGF to inhibit the hedgehog
pathway was apparently mediated by both JNK and ERK, with
JNK predominating.
Intriguingly, two groups have narrowed down the region of Gli1
that responds to MAPK signaling. Riobo, et al. [76] found that
Gli1 transcriptional activity was enhanced by activation of ERK,
and that the first 130 residues of the 1100+-residue Gli1 protein
were required for sensing the ERK pathway. Likewise, Seto et al.
[79], using a similar assay, mapped the ERK-responsive regions to
the first 116 residues of Gli1. Hence, two independent studies have
narrowed down the ERK-responsive region of Gli1 to a small
portion of the protein that contains the D-site identified in this
work. This region appears to be a ‘hotspot’’ for the regulation of
Gli activity [84,104,105].
To summarize, there is considerable compelling recent evidence
for MAPK-mediated regulation of Gli transcription factors, and
for the importance of this crosstalk in stem cell development and
cancer. Our study, however, is the first to provide direct evidence
that ERK or JNK either bind to or phosphorylate Gli trans-
cription factors.
Specificity of docking sites and docking-directed
phosphorylation
A final set of observations that emerge from the present study
concerns the specificity of docking site action. It has been
established that different docking sites in the same substrate can
direct MAPKs to distinct target phosphosites. For example, an
FXFP-class docking site in Elk-1 directs ERK to phosphorylate
Ser383, whereas the D-site in Elk-1 directs ERK to phosphorylate
other residues [106]. Similarly, in the paralogous transcription
factor Net, ERK and JNK, via different D-sites, bind to and
phosphorylate separate domains of the protein [54]. Here, we
found evidence of a different phenomenon: the same D-site can
direct different MAPKs to distinct phosphosites on the same
substrate. In Gli3, Ser343 received the bulk of JNK-mediated
phosphorylation directed by the 281–300 D-site. In contrast, ERK
phosphorylation by the same D-site was directed both to Ser343
and to other residue(s). Even more strikingly, in Gli1 Ser130
received the bulk of JNK-mediated phosphorylation directed by
the 72–91 D-site, whereas this phosphosite was phosphorylated
hardly at all by ERK; instead the same D-site directed ERK to
phosphorylate completely different residue(s).
In conclusion, using D-finder, a tool developed to search
genome databases for JNK-docking sites, we have discovered new
MAPK docking sites, binding partners, and substrates, including
the hedgehog-pathway transcription factors Gli1 and Gli3.
Methods
D-learner hidden Markov model
A profile HMM architecture, composed of linked main, insert,
and delete states was implemented in the programming language
Java to perform the computational analysis and prediction. An
HMM model of length 19 was used to match the average length of
the available docking site sequences. The initial state transition
and emission probabilities were uniformly set across the model
prior to training. Using the available, experimentally determined
docking site sequences, the HMM was trained using Viterbi
learning [34] by running each sequence through the model and
updating the transition and emission probabilities accordingly.
This procedure was repeated 300 times allowing convergence of
the sum of the Viterbi probabilities to a constant value.
The probabilistic score produced by D-finder is technically
called the Viterbi score. This score is generated by calculating the
log-likelihood of the D-matcher-approved string (as a complete
Viterbi path in the HMM) based on the trained model. The
greater the generated score (i.e., the closer to 1), the closer the
likelihood is to the optimal Viterbi path. In other words, the
Viterbi score is the probability P
V of the most likely HMM path
for the given sequence. The most likely path is a sequence of state
transitions and state emissions. Each transition and each emission
has a probability. These probabilities get multiplied with each
other along the most likely path; as a result, Viterbi scores are
typically very small numbers.
D-matcher algorithm
The D-matcher algorithm was predicated on the following three
pieces of expert knowledge, specifically drawn from general trends
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unpublished data): (1) a w-X-w submotif, in which the middle
residue is not itself strongly hydrophobic, is optimal for high-
affinity JNK binding; (2) binding affinity is proportional to the
number of basic residues in the basic submotif, and gaps in
between the basic residues result in decreased binding affinity (3);
there is a limit to the allowable distance between these two
submotifs. The first version of D-matcher first identified all
hydrophobic-X-hydrophobic regions (with V, I, L, M defined as
hydrophobics, and X not allowed to be a hydrophobic). Substrings
12 amino acids long preceding each Q-X-Q were then pulled out
for further analysis. With each substring, a local-to-global
alignment [107] was performed using a 3 basic residue motif as
the local sequence; this was used to give a numerical score.
D-matcher consistently gave higher scores to the wild type
MKK4 D-site than to point mutants that have been shown
experimentally to reduce JNK binding affinities ([32], DTH
unpublished data). Also, when tested on other known JNK-binding
proteins, D-matcher correctly ranked the known D-site higher
compared to other potential D-sites (data not shown).
The simplified D-matcher incorporated into D-finder was
designed to be a minimal prescreen that simply checks for a basic
residue followed after a spacer of 1–3 residues by a hydrophobic-
X-hydrophobic (as defined above).
D-finder algorithm
D-finder is a hybrid of D-matcher and D-learner. Specifically, a
modified D-matcher is used to select suitable strings to pass to D-
learner, which then assigns a standard HMM Viterbi probability
score. Each full-length sequence was assigned a score equal to the
score of its highest probability D-matcher-passing string. The
sequences were then ranked yielding a sorted list of predicted D-
sites (see Table 1 in Table S1). D-finder is written in Java; the code
is downloadable from http://dfinder.sourceforge.net as a .zip file
that contains the Java files along with the original training set file,
a sample testing file, and a README file.
Transcriptome screening and human genes
The translated human transcriptome was obtained from the
UCSC Genome Browser (hg19; 33,730 protein sequences). The
human MAPK genes used in this study were JNK1a1 (MAPK8,
NCBI Accession Number NM_002750), JNK2a2 (MAPK9,
NM_002752), JNK3a1 (MAPK10, NM_002753) and ERK2
(MAPK1, NM_002754). Accession numbers for the MAPK
substrates examined in this work are given in Fig. 3 and Table S1.
Peptide array
Custom synthesis of the peptide arrays used in this study was
performed by JPT (Berlin, Germany), as described elsewhere [70].
The 17-mer peptides (see Table 3 in Table S1) were chemically
linked to a nitrocellulose membrane via the C-terminus. Two
separate array designs were synthesized twice each. Design 1 had
four control spots (two positive, two negative) and 42 predicted D-
site peptides synthesized in duplicate (total spots/array=96).
Design 2 had the same four controls, 18 training set D-site
peptides, and 30 predicted D-site peptides synthesized in duplicate
(total spots/array=104). The membrane was probed with [
35S]-
methionine labeled JNK1 as described elsewhere [32].
Biochemical workup
An outline of our strategy to efficiently test selected candidates is
as follows: cDNA clones of candidates were obtained from the
mammalian gene collection [108] where available (in some cases
only fragments were available). Open reading frames were
subcloned downstream of a bacteriophage RNA polymerase
promoter, and the encoded protein was produced in radiopure
form by coupled in vitro transcription/translation, as described
elsewhere [109]. The in vitro-translated candidate protein was then
used in a binding assay (a.k.a. a GST pull-down assay) with various
GST-MAPKs. If a candidate exhibited MAPK binding, the
predicted D-site was mutated or deleted and the mutant protein
was retested. Selected candidates that exhibited D-site-dependent
binding were then subcloned into bacterial expression vectors as
GST-fusions. This step often involved considerable optimization
to find a suitable fragment that was expressed as soluble protein at
a reasonable yield. Purified GST-fusion proteins were then used as
substrates in protein kinase assays with purified active MAPK
enzymes.
Plasmids for in vitro transcription and translation
cDNA clones from mammalian gene collection [108] were
obtained from Open Biosystems (Huntsville, AL) or OriGene
(Rockville, MD). The Gli3 plasmid was a gift of Dr. Bert
Vogelstein, Johns Hopkins University. Regions of interest were
amplified by PCR using Pfu Ultra DNA polymerase (Stratagene).
PCR products were purified (Qiagen) and digested with restriction
enzymes designed into the primers, run on 1% agarose gels, and
excised for gel extraction (Qiagen). Digested, gel purified products
were inserted into pGEM-4ZStop, a variant of pGEM4Z that
contains multiple stop codons downstream of the cloning site (a gift
from A. Jane Bardwell of this laboratory). Plasmid sequences were
verified by DNA sequencing (Cogenics). To create D-site mutant
(DSM) constructs, basic and hydrophobic residues in the predicted
D-site were substituted with alanine residues using appropriate
primers and the Quickchange site-directed mutagenesis kit
(Stratagene). Mutations were verified by DNA sequencing.
Plasmids for the production of GST fusion proteins and
cell culture
Open reading frames of interest were subcloned into pcDNA
3.1 (+) and pGEX-LB (a derivative of PGEX-4T-1) as described
[99]. New primers were designed for amplification of smaller
fragments, where appropriate.
In vitro transcription and translation
Proteins labeled with [
35S]-methionine were produced by
coupled transcription and translation reactions (SP6, Promega).
Translation products were partially purified by ammonium sulfate
precipitation [109] and resuspended in Binding Buffer (20mM
Tris-HCl (pH 7.5), 125mM KOAc, 0.5mM EDTA, 1mM DTT,
0.1% (v/v) Tween20, 12.5% (v/v) Glycerol). Comparable
translation products were normalized for GST pull down assays
by SDS-PAGE and quantification using a Typhoon Phosphor-
Imager (Amersham Biosciences).
GST pull down assays
Comparable amounts of [
35S]-methionine labeled proteins (i.e.,
wild-type vs. D-site mutant) were pre-cleared against BSA-blocked
glutathione Sepharose beads, then incubated with GST-MAPK
fusion proteins or GST alone at 30uC for 15 min followed by an
additional 30 min at room temperature with gentle rocking.
Complexes were then sedimented, washed extensively with
binding buffer, and heated in reducing SDS sample buffer.
Samples were separated by SDS-PAGE, fixed in 40% Methanol/
12% Acetic Acid, Coomassie Blue stained (using Gelcode Blue,
Pierce), dried, visualized and quantified using a PhosphorImager.
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lanes were normalized to the 5% input lane.
Purification of recombinant GST proteins
Expression of recombinant GST fusion proteins was induced in
Escherichia coli BL21 cells (Stratagene) at 30uC for 2 h by addition
of 1-thio-b-D-galactopyranoside [IPTG, 0.6 mM final]. Cell
pellets were resuspended in lysis buffer (16 PBS, 1mM EDTA,
5mM DTT, 0.1% Triton, 1mM PMSF, 15% Glycerol), and the
resulting extract was sonicated, clarified with 20% Triton X-100,
and centrifuged at 12,0006g for 10 min to remove cell debris and
nucleic acids. GST fusion proteins contained within the superna-
tants were purified by affinity chromatography using glutathione-
Sepharose (Amersham Biosciences), eluted from beads using
10mM reduced glutathione, and dialyzed overnight against lysis
buffer. Eluted proteins were quantified against BSA standards.
Protein kinase assays
Kinase reactions (20 ml) contained 16 MAP Kinase Buffer
(50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 1 mM EGTA, and
2 mM DTT), 50 mM ATP, 1 mCi of [c-
32P]-ATP, enzyme, and
substrate. Enzymes were: JNK1a1, active; JNK2a2, active
(Upstate); JNK3/SAPK1b, active (all from Upstate Biochemi-
cals/Millipore); ERK2, active (New England Biosciences). Sub-
strates were: GST-hnRNP-K w/D, 1 mM (896 ng/20 ml); GST-
hnRNP-K w/oD, 1 mM (818 ng/20 ml); GST-PPM1J WT and
DSM, 0.5 mM (750 ng/20 ml); GST-Gli3280–478 WT and DSM,
0.5 mM (465 ng/20 ml); GST-Gli168–232 WT and DSM, 1 mM
(856 ng/20 ml). Reactions were incubated at 30uC for 30 min,
then stopped with SDS sample buffer, separated by SDS-PAGE,
fixed in 40% Methanol/12% Acetic Acid, Gelcode Blue stained,
dried, and visualized using a PhosphorImager. Unit definitions for
enzymes were as supplied by the manufacturer. Note that the unit
definition for ERK2 and the JNK proteins are different. For
ERK2, 10 units is about 1 ng of enzyme, corresponding to a
concentration of 1.2 nM in a 20 ml reaction. For the JNK proteins,
1 ng of enzyme corresponds to about 0.5 milliunits (mU).
Tissue culture and transfection
Cos-1 cells were cultured using Dulbecco’s modified Eagle’s
medium enriched with 10% heat-inactivated fetal bovine serum
(Invitrogen), penicillin, streptomycin, and sodium bicarbonate.
The cells were seeded at a density of 3610
5 cells per well in a 6-
well dish in antibiotic free media. The culture was maintained
in a humidified environment at 37uC and 5% CO2. Transient
transfection was performed with Lipofectamine (Invitrogen)
following the manufacturer’s recommended procedures.
Immunoprecipitation kinase assays
Cos-1 cells were transfected with 1 mg of plasmid DNA
encoding either V5-tagged wild-type (WT) PPM1J, docking site
mutated (DSM) PPM1J, or empty vector. After 16 h, the cells were
harvested and lysed in 200 ml HEPES Lysis Buffer (HLB, 20 mM
Hepes (ph 7.4), 137 mM NaCl, 2 mM EDTA, 10% glycerol (v/v),
1% Triton X-100 (v/v), 25 mM b-glycerophosphate, 1 mM
Sodium Vandate, 1:100 protease inhibitor cocktail (Sigma)) and
centrifuged at 14,0006g for 15 min at 4uC. Forty ml of each
supernatant was removed for immunoblotting. The PPM1J WT
and D-site mutant supernatants were cleared with 20 mlo fa5 0 %
slurry of Protein G Plus/Protein A-agarose beads for 30 min at
4uC. The cleared lysates were incubated for 30 min at 4uC with
2 ml of anti-V5 antibody (Invitrogen). Twenty ml of beads (50%
slurry) were added and incubated overnight at 4uC. Complexes
were sedimented and then washed twice with HLB plus 0.1%
Triton X-100 and once with MAP Kinase buffer. The immuno-
precipitated complexes were then used in a kinase assay with
1 mU of active JNK1a1.
Liquid chromatography-tandem mass spectrometry (LC
MS/MS)
Phosphorylation reactions were as described above except that
ATP was raised to 200 mM and the radioactive ATP tracer was
omitted. Following real or mock phosphorylation reactions, the
products were separated by SDS-PAGE, and bands corresponding
to the mass of the Gli3 fragments were excised from the gel and
digested with chymotrypsin. The resulting peptide digests were
extracted and analyzed by LC MS/MS as described [110]. Briefly,
the LC analysis was performed using a capillary column (100 mm
ID6150 mm long) packed with C18 resins (GL Sciences) and the
peptides were eluted using a linear gradient of 2–35% B in 35 min;
(solvent A: 100% H2O/0.1% formic acid; solvent B: 100%
acetonitrile/0.1% formic acid). A cycle of one full FT scan mass
spectrum (350–1800 m/z, resolution of 60,000 at m/z 400) was
followed by ten data-dependent MS/MS acquired in the linear ion
trap with normalized collision energy (setting of 35%). Target ions
selected for MS/MS were dynamically excluded for 30 s.
Protein identification and characterization was carried out by
database searching using Protein Prospector [110]. LC MS/MS
data was extracted, and submitted to database searching using the
Batch-Tag against a decoy database consisting of a normal
SwissProt database including the engineered Gli3 sequences
concatenated with its random version. The mass accuracy for
parent ions and fragment ions were set as 620 ppm and 0.5 Da,
respectively. Phosphorylation of Serine and Threonine was
selected as the variable modification. MS/MS spectra of
phosphorylated peptides were inspected manually.
Supporting Information
Table S1 List of top D-finder predictions.
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